Changing the paradigm in conducting randomized ... [J Clin Oncol. 2009] - PubMed

Related citations

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. [J Clin Oncol. 2009]
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.
Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, Harper PG, Dunn J, Tudur-Smith C, West J, et al. J Clin Oncol. 2009 Nov 20; 27(33):5513-8. Epub 2009 Oct 26.
Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer. [J Clin Oncol. 2009]
Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.
Starling N, Watkins D, Cunningham D, Thomas J, Webb J, Brown G, Thomas K, Oates J, Chau I. J Clin Oncol. 2009 Nov 20; 27(33):5499-505. Epub 2009 Oct 26.
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. [J Clin Oncol. 2005]
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.
Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, André T, Zaniboni A, Ducreux M, Aitini E, Taïeb J, et al. J Clin Oncol. 2005 May 20; 23(15):3509-16.
Review Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy. [Cancer Treat Rev. 2009]
Review Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy.
Rivera F, López-Tarruella S, Vega-Villegas ME, Salcedo M. Cancer Treat Rev. 2009 Jun; 35(4):335-9. Epub 2009 Jan 7.
Review Capecitabine plus oxaliplatin for the treatment of colorectal cancer. [Expert Rev Anticancer Ther. 2008]
Review Capecitabine plus oxaliplatin for the treatment of colorectal cancer.
Carrato A, Gallego-Plazas J, Guillén-Ponce C. Expert Rev Anticancer Ther. 2008 Feb; 8(2):161-74.

See reviews... See all...

Cited by 1 PubMed Central article

Current and emerging therapies for the treatment of pancreatic cancer. [Onco Targets Ther. 2010]
Current and emerging therapies for the treatment of pancreatic cancer.
Moss RA, Lee C. Onco Targets Ther. 2010 Sep 7; 3:111-27. Epub 2010 Sep 7.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Changing the paradigm in conducting randomized clinical studies in advanced panc...
Changing the paradigm in conducting randomized clinical studies in advanced pancreatic cancer: an opportunity for better clinical development.
J Clin Oncol. 2009 Nov 20 ;27(33):5487-91. Epub 2009 Oct 26 .

PubMed
Regular sauna bathing and the incidence of common colds.
Regular sauna bathing and the incidence of common colds.
Ann Med. 1990 ;22(4):225-7.

PubMed
Brush-evoked allodynia predicts outcome of spinal cord stimulation in complex re...
Brush-evoked allodynia predicts outcome of spinal cord stimulation in complex regional pain syndrome type 1.
Eur J Pain. 2010 Feb ;14(2):164-9. Epub 2009 Nov 25 .

PubMed
Intravenous magnesium for complex regional pain syndrome type 1 (CRPS 1) patient...
Intravenous magnesium for complex regional pain syndrome type 1 (CRPS 1) patients: a pilot study.
Pain Med. 2009 Jul-Aug ;10(5):930-40. Epub 2009 Jun 1 .

PubMed
Serum response factor: master regulator of the actin cytoskeleton and contractil...
Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus.
Am J Physiol Cell Physiol. 2007 Jan ;292(1):C70-81. Epub 2006 Aug 23 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Changing the paradigm in conducting randomized clinical studies in advanced pancreatic cancer: an opportunity for better clinical development.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information